Physician profile
Steven E Ozeran
NPI 1316911571
$9,305.76
in general payments reported to CMS, 2019-2025
7 companies · $252 in 2025
The $252 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,436 · 2020: $62.00 · 2021: $2,182 · 2022: $32.17 · 2023: $148 · 2024: $194 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $594.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $8,695.40 | 2019-2022 | |
| Kerecis Limited | $296.06 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $191.43 | 2023-2025 | Puraply Wound Matrix, Puraply |
| Abbvie INC. | $64.63 | 2023 | |
| Polynovo North America LLC | $27.51 | 2025 | Novosorb Btm |
| Pacira Pharmaceuticals Incorporated | $16.17 | 2021 | |
| Mentor Worldwide LLC | $14.56 | 2023 | Mentor Memoryshape Breast Implant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Ozeran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.